title: Silent mixed corticotroph and somatotroph macroadenomas presenting with pituitary apoplexy.
abstract: We discuss three unique cases of pituitary macroadenoma presenting with pituitary hemorrhage but without typical endocrine symptomatology. Immunohistochemical analysis indicated positive reactivity for adrenocorticotropic hormone (ACTH) and growth hormone (GH), and in situ hybridization indicated the expression of proopiomelanocortin (POMC) and GH mRNA. We designated these cases silent mixed corticotroph and somatotroph adenoma. Patient 1 was a 30-year-old man, patient 2 was a 29-year-old woman, and patient 3 was a 59-year-old woman. All patients presented with a headache of sudden onset and visual disturbance. The patients did not exhibit typical Cushing's or acromegalic features. Serum ACTH level was remarkably elevated in patient 1, and slightly elevated in patients 2 and 3. In all patients, serum GH levels were within normal range and magnetic resonance imaging revealed an intra- and suprasellar mass with pituitary hemorrhage. Transnasal pituitary surgery in the three patients disclosed a pituitary adenoma producing ACTH and GH. In patient 2, the residual adenoma reappeared along with an intratumoral hemorrhage, and was resected by secondary transnasal surgery. Silent mixed corticotroph and somatotroph adenomas are characterized by the following: no endocrine symptoms; presentation dominated by mass effect symptoms; macroadenoma presenting with acute pituitary hemorrhage; and production of both ACTH and GH.
authors.affiliation: Department of Neurosurgery, Showa University School of Medicine, Tokyo, Japan. takumi@med.showa-u.ac.jp
authors.forename: T
authors.initials: T
authors.lastname: Abe
authors.forename: M
authors.initials: M
authors.lastname: Taniyama
authors.forename: B
authors.initials: B
authors.lastname: Xu
authors.forename: H
authors.initials: H
authors.lastname: Ozawa
authors.forename: N
authors.initials: N
authors.lastname: Kawamura
authors.forename: M
authors.initials: M
authors.lastname: Shimazu
authors.forename: K
authors.initials: K
authors.lastname: Sasaki
authors.forename: H
authors.initials: H
authors.lastname: Izumiyama
authors.forename: M
authors.initials: M
authors.lastname: Kushima
authors.forename: J
authors.initials: J
authors.lastname: Kuwazawa
authors.forename: T
authors.initials: T
authors.lastname: Sano
authors.forename: K
authors.initials: K
authors.lastname: Matsumoto
mesh_terms: D000236:Adenoma / Q000737:chemistry / Q000473:pathology*; D000324:Adrenocorticotropic Hormone / Q000032:analysis; D000328:Adult; D003937:Diagnosis, Differential; D005260:Female; D019382:Human Growth Hormone / Q000032:analysis / Q000235:genetics; D006801:Humans; D017403:In Situ Hybridization; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D010899:Pituitary Apoplexy / Q000473:pathology*; D010911:Pituitary Neoplasms / Q000737:chemistry / Q000473:pathology*; D011333:Pro-Opiomelanocortin / Q000032:analysis / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis
chemical_list: D012333:RNA, Messenger; D019382:Human Growth Hormone; D011333:Pro-Opiomelanocortin; D000324:Adrenocorticotropic Hormone